MedTrace Logo

Mineral Bone Disorder in Dialysis

NCT07212972 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 167

Last updated 2025-10-08

No results posted yet for this study

Summary

This study was conducted with 167 dialysis patients at Erciyes University Faculty of Medicine, Department of Internal Medicine, Department of Nephrology, and Dialysis Unit, with the approval of the Ethics Committee of Erciyes University Medical Faculty (date: 25.09.2019, no: 2019/673).

Patients aged ≥18 years, undergoing dialysis treatment, and having available data on serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium levels within the last six months were included in the study.

Conditions

  • Chronic Kidney Failure
  • Chronic Kidney Disease-Mineral and Bone Disorder
  • Dialysis
  • Hemodialysis

Interventions

OTHER

Hemodialysis or peritoneal Dialysis

Hemodialysis or peritoneal Dialysis

Sponsors & Collaborators

  • Çanakkale Onsekiz Mart University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-25
Primary Completion
2020-04-15
Completion
2020-06-20
FDA Device
Yes

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07212972 on ClinicalTrials.gov